Page contents Full notification Final report General information GMO characterization European Commission administrative Information Return to search

Full notification Final report - General information Notification Number B/ES/23/09 Member State to which the notification was sent Spain Date of acknowledgement from the Member State Competent Authority 26/09/2023 Title of the Project A single-arm, open-label, multi-centre, phase I/II study evaluating the safety and clinical activity of QEL-001, an autologous CAR T regulatory cell treatment targeting HLA-A2, in HLA-A2/ A28neg patients that have received an HLA-A2pos liver transplant Proposed period of release: 30/11/2023 to 31/01/2040 Name of the Institute(s) or Company(ies) Quell Therapeutics Limited, Translation and Innovation Hub, 84 Wood Lane, London, UK
Is the same GMO been notified elsewhere by the same notifier? No Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: Other Identity of the GMO: Homo Sapiens Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Genus: Homo Species: Homo Sapiens Subspecies: Strain: N/A Pathovar: N/A European Commission administrative Information Consent given by the Member State Competent Authority: Yes
01/10/2024